beta-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-alpha-D-GalpOCH2CH2NH2

Term ID

CHEBI:136764

Synonyms

2-aminoethyl beta-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-alpha-D-galactopyranoside
2-aminoethyl beta-D-glucosyl-(1->4)-alpha-D-glucosyl-(1->4)-alpha-D-galactoside
beta-D-Glc-(1->3)-alpha-D-Glc-(1->4)-alpha-D-GalO[CH2]2NH2
beta-D-Glc-(1->4)-alpha-D-Glc-(1->4)-alpha-D-GalOCH2CH2NH2
beta-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-alpha-D-GalpO[CH2]2NH2
Glcbeta1-4Glcalpha1-4GalalphaOCH2CH2NH2

Definition

An α-D-glucoside that is the 2-aminoethyl glycoside of a trisaccharide consisting of β-D-glucosyl, α-D-glucosyl and α-D-galactosyl residues linked sequentially (1→4).

References

patent:AU2015323651
pubmed:28275152
reaxys:29433973

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-alpha-D-GalpOCH2CH2NH2

Phenotype where environments contain beta-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-alpha-D-GalpOCH2CH2NH2

Phenotype modified by environments containing beta-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-alpha-D-GalpOCH2CH2NH2

Phenotype affecting beta-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-alpha-D-GalpOCH2CH2NH2

Human Disease Model